Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Prostate Cancer

Free Subscription Articles published in Urology Retrieve available abstracts of 147 articles: HTML format

Single Articles

November 2023
1. MYERS JB, Hernandez BS, McCormick B, Ramsay J, et al
   Comparison of Urinary Diversion in Patients with Prostatic Fistula to Those with Localized Radiation Injury after Radiotherapy for the Treatment of Prostate Cancer.
   Urology. 2023 Nov 29:S0090-4295(23)01029-4. doi: 10.1016/j.urology.2023.
   PubMed     Abstract available
   
   
   
2. STENSLAND KD, Caram ME, Herr DJ, Burns JA, et al
   National long-term survival estimates after radical prostatectomy for prostate cancer.
   Urology. 2023 Nov 9:S0090-4295(23)00987-1. doi: 10.1016/j.urology.2023.
   PubMed     Abstract available
   
   
   
3. GERETA S, Hung M, Alexanderani MK, Robinson BD, et al
   Evaluating the Learning Curve for In-office Freehand Cognitive Fusion Transperineal Prostate Biopsy.
   Urology. 2023;181:31-37.
   PubMed     Abstract available
   
   
   
4. ARCEO-OLAIZ R, Smith EA, Stokes C, Eaton BR, et al
   Use of Perirectal Hyaluronic Acid Spacer Prior to Radiotherapy in a Pediatric Patient With Bladder Rhabdomyosarcoma: A Case Report.
   Urology. 2023;181:136-140.
   PubMed     Abstract available
   
   
   
5. ENDERS JJ, Pinto PA, Xu S, Gomella P, et al
   A Novel Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy Technique Using Transperineal Ultrasound: An Initial Experience.
   Urology. 2023;181:76-83.
   PubMed     Abstract available
   
   
   October 2023
6. HEBERT K, Bruno A, Matta R, Horns J, et al
   Impact of Prostate Cancer Related Genitourinary Radiation Injury on Mental Health Diagnosis and Treatment: Assessment of 55,425 Men.
   Urology. 2023 Oct 12:S0090-4295(23)00866-X. doi: 10.1016/j.urology.2023.
   PubMed     Abstract available
   
   
   
7. REZAEE ME, Gardner U, Alshak MN, Greco SC, et al
   Title: Effect of Transperineal versus Transrectal Prostate Biopsy on the Quality of Hydrogel Spacer Placement in Men prior to Radiation Therapy for Prostate Cancer.
   Urology. 2023 Oct 5:S0090-4295(23)00858-0. doi: 10.1016/j.urology.2023.
   PubMed     Abstract available
   
   
   September 2023
8. MADHAVAN K, Jena R, Viswas MR, Kaushal D, et al
   Does Radical Local Treatment in oligometastatic Prostate Cancer improve Overall Survival- A systematic review and meta-analysis.
   Urology. 2023 Sep 27:S0090-4295(23)00833-6. doi: 10.1016/j.urology.2023.
   PubMed     Abstract available
   
   
   
9. BRAUN AE, Cowan JE, Hampson LA, Broering JM, et al
   Association between common urologic medications and onset of Alzheimer's disease and related dementias in men with prostate cancer managed by different primary treatment modalities.
   Urology. 2023 Sep 7:S0090-4295(23)00740-9. doi: 10.1016/j.urology.2023.
   PubMed     Abstract available
   
   
   
10. ODERDA M, Grimaldi S, Rovera G, Delsedime L, et al
    Robot-assisted PSMA-radioguided surgery to assess surgical margins and nodal metastases in prostate cancer patients: report on three cases using an intraoperative PET-CT specimen imager.
    Urology. 2023 Sep 3:S0090-4295(23)00730-6. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
11. XU AJ, Panken EJ, Gonzales-Alabastro CD, Zhang H, et al
    Urologists and Lesbian, Gay, Bisexual, Transgender, or Queer Patients: A Survey-based Study of the Practice Patterns, Attitudes, and Knowledge Base of Urologists Toward Their Lesbian, Gay, Bisexual, Transgender, or Queer Patients.
    Urology. 2023;179:71-79.
    PubMed     Abstract available
    
    
    August 2023
12. AMBINDER D, Lubarsky R, Barnett J, Choudhury M, et al
    Author Reply to the Editorial Comment on Prostate Cancer: Under-representation of African American Men in Research Studies Used in the Latest NCCN Guidelines.
    Urology. 2023 Aug 27:S0090-4295(23)00629-5. doi: 10.1016/j.urology.2023.
    PubMed    
    
    
    
13. IBILIBOR C
    Urology Editorial Comment for "Prostate Cancer: Under-representation of African American Men in Research Studies Used in the Latest NCCN Guidelines".
    Urology. 2023 Aug 27:S0090-4295(23)00628-3. doi: 10.1016/j.urology.2023.
    PubMed    
    
    
    
14. BHANJI Y, Mamawala M, de la Calle CM, Landis P, et al
    Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) MRI Scoring to Predict Clinical Outcomes in Active Surveillance for Grade Group 1 Prostate Cancer.
    Urology. 2023 Aug 1:S0090-4295(23)00658-1. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
15. RAMOS-CARPINTEYRO R, Ferguson EL, Chavali JS, Geskin A, et al
    Single-port Transvesical Robot-assisted Radical Prostatectomy: The Surgical Learning Curve of the First 100 Cases.
    Urology. 2023;178:76-82.
    PubMed     Abstract available
    
    
    July 2023
16. PAULA DOMINO M, Vertosick EA, Vickers AJ, Eastham JA, et al
    The association between low preoperative serum testosterone and post radical prostatectomy urinary function.
    Urology. 2023 Jul 27:S0090-4295(23)00654-4. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
17. LUBARSKY R, Ambinder D, Barnett J, Choudhury M, et al
    Prostate Cancer: Under-representation of African American men in research studies used in the latest NCCN guidelines.
    Urology. 2023 Jul 19:S0090-4295(23)00599-X. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
18. COSKUN B, Ocakoglu G, Yetemen M, Kaygisiz O, et al
    CAN CHATGPT, AN ARTIFICIAL INTELLIGENCE LANGUAGE MODEL, PROVIDE ACCURATE AND HIGH-QUALITY PATIENT INFORMATION ON PROSTATE CANCER?
    Urology. 2023 Jul 3:S0090-4295(23)00570-8. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
19. DHIR A, Ellimoottil CS, Qi J, Zhu A, et al
    Intra-practice Urologist-level Variation in Targeted Fusion Biopsy Outcomes.
    Urology. 2023;177:122-127.
    PubMed     Abstract available
    
    
    
20. MICHAEL ZD, Kotamarti S, Deivasigamani S, Seguier D, et al
    A Comprehensive Assessment of the Utility of Transperineal Template Prostate Mapping Biopsy: A 13-year Experience.
    Urology. 2023;177:115-121.
    PubMed     Abstract available
    
    
    
21. VALLI J, Haapiainen H, Murtola TJ, Huhtala H, et al
    Visual Analogue Scale and Expanded Prostate Cancer Index Composite-26 in the Evaluation of Urinary Continence Recovery After Three-Dimensional Laparoscopic Radical Prostatectomy, a Single-Center Prospective Registered Study.
    Urology. 2023;177:103-108.
    PubMed     Abstract available
    
    
    
22. CRISOSTOMO-WYNNE T, Lee K, Speir R
    Robot-assisted Laparoscopic Prostatectomy After SpaceOAR Placement.
    Urology. 2023;177:228-229.
    PubMed     Abstract available
    
    
    
23. DERIGS F, Kowalewski KF, Hartung FO, Waldbillig F, et al
    A Matched-pair Analysis Comparing Systematic Prostate Biopsy by Conventional Transrectal Ultrasound-guidance Versus Software-based Predefined 3D-Guidance.
    Urology. 2023;177:128-133.
    PubMed     Abstract available
    
    
    June 2023
24. BENIDIR T, Lone Z, Wood A, Abdallah N, et al
    Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSA.
    Urology. 2023;176:115-120.
    PubMed     Abstract available
    
    
    
25. FEIERTAG N, Tawfik MM, Loloi J, Patel RD, et al
    Should Men Eat More Plants? A Systematic Review of the Literature on the Effect of Plant-Forward Diets on Men's Health.
    Urology. 2023;176:7-15.
    PubMed     Abstract available
    
    
    May 2023
26. HEBERT KJ, Matta R, Fendereski K, Horns JJ, et al
    Genitourinary Radiation Injury Following Prostate Cancer Treatment: Assessment of Cost and Health Care System Burden.
    Urology. 2023 May 30:S0090-4295(23)00457-0. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
27. LONERGAN PE, Baskin A, Greenberg SA, Mohamad O, et al
    The long-term incidence and quality of life outcomes associated with treatment-related toxicities of external beam radiotherapy for prostate cancer.
    Urology. 2023 May 25:S0090-4295(23)00444-2. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
28. GOLD SA, Goueli R, Mostardeiro TR, Carpinito GP, et al
    Optimal Prostate Cancer Diagnostic Pathways for Men with Prostatomegaly in the MRI Era.
    Urology. 2023 May 12:S0090-4295(23)00395-3. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
29. MAGANTY A, Hollenbeck BK, Kaufman SR, Oerline MK, et al
    Practice Competition and Treatment of Newly Diagnosed Prostate Cancer.
    Urology. 2023 May 3:S0090-4295(23)00383-7. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
30. MORRIS KE, Kotamarti S, Polascik TJ, Moul JW, et al
    Re-thinking How We Use Prostate Health Index for African American Men.
    Urology. 2023;175:144-150.
    PubMed     Abstract available
    
    
    
31. WU S, Feldman AS, Kim MM, Lin SX, et al
    Gleason Grade Group Concordance between Systematic Template Combining Magnetic Resonance Imaging Fusion Targeted Biopsy and Radical Prostatectomy Specimens: A Comparison of Transperineal and Transrectal Approaches.
    Urology. 2023;175:151-156.
    PubMed     Abstract available
    
    
    
32. SCOVELL JM, Stovsky M, Partin A, Lotan Y, et al
    IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study.
    Urology. 2023;175:132-136.
    PubMed     Abstract available
    
    
    
33. P AS, Patel H, Chandrashekar V, De Cruz A, et al
    Hematuria in an Adolescent Boy With Long-Standing Prostatic Utricle Cyst-An Ominous Sign.
    Urology. 2023;175:187-189.
    PubMed     Abstract available
    
    
    April 2023
34. BULLER D, Sahl J, Staff I, Tortora J, et al
    Prostate Cancer Detection and Complications of Transperineal versus Transrectal MRI-Fusion Guided Prostate Biopsies.
    Urology. 2023 Apr 12:S0090-4295(23)00312-6. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
35. PETERSON DJ, Bhambhvani HP, Baird DRW, Li S, et al
    Prosteria - National Trends and Outcomes of More Frequent Than Guideline Recommended Prostate Specific Antigen Screening.
    Urology. 2023;174:92-98.
    PubMed     Abstract available
    
    
    March 2023
36. PREMO H, Gordee A, Lee HJ, Scales CD Jr, et al
    Disparities in Prostate Cancer Screening for Transgender Women: An Analysis of the MarketScan Database.
    Urology. 2023 Mar 25:S0090-4295(23)00264-9. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
37. SADIGHIAN M, Hakam N, Amend G, Shaw NM, et al
    Radiation-induced fistulas in patients with prior pelvic radiotherapy for prostate cancer: a systematic review and meta-analysis.
    Urology. 2023 Mar 22:S0090-4295(23)00259-5. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
38. JOYCE DD, Tilburt JC, Pacyna JE, Cina K, et al
    The Impact of Within-Consultation and Pre-Consultation Decision Aids for Localized Prostate Cancer on Patient Knowledge: Results of a Patient-Level Randomized Trial.
    Urology. 2023 Mar 8:S0090-4295(23)00199-1. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
39. REZAEE ME, Li H, Pienta KJ
    An Enhancing Renal Mass in Metastatic Prostate Cancer.
    Urology. 2023 Mar 7:S0090-4295(23)00203-0. doi: 10.1016/j.urology.2023.
    PubMed    
    
    
    February 2023
40. YANG L, Harper A, Imm KR, Grubb RL 3rd, et al
    Association between pre-surgical weight status and urinary and sexual function in prostate cancer patients treated by radical prostatectomy: a prospective cohort study.
    Urology. 2023 Feb 23:S0090-4295(23)00174-7. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
41. CRIBBS KA, Manning EF, Zhou J, Lahue BJ, et al
    Real-World Comparative Safety and Effectiveness of Irreversible Electroporation and High-Intensity Focused Ultrasound for Prostate Cancer Ablation.
    Urology. 2023 Feb 1:S0090-4295(23)00071-7. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available
    
    
    
42. HAAPIAINEN H, Valli J, Murtola T, Huhtala H, et al
    Visual Analogue Scale (VAS) in the Evaluation of Functional Outcomes After Three-dimensional Laparoscopic Prostatectomy.
    Urology. 2023;172:121-125.
    PubMed     Abstract available
    
    
    January 2023
43. GANGWISH D, Zwaans BMM, Miriani P, Dejoie W, et al
    Prevalence and Causes of Discontinuation of Androgen Receptor Inhibitors in Advanced Prostate Cancer Patients and Analysis of Physician Management to Increase Duration of Therapy.
    Urology. 2023 Jan 2:S0090-4295(22)01099-8. doi: 10.1016/j.urology.2022.
    PubMed     Abstract available
    
    
    
44. PRILLAMAN GE, Tuong M, Yeaman CT, Farhi J, et al
    Complex Foley Catheter Placement After Radical Prostatectomy.
    Urology. 2023;171:251.
    PubMed     Abstract available
    
    
    
45. KRUGHOFF K, Livingston AJ, Inouye B, Peterson AC, et al
    Indications and Outcomes for Intermittent Catheterization following Bulbar AUS Cuff Placement.
    Urology. 2023;171:216-220.
    PubMed     Abstract available
    
    
    
46. ABOU ZEINAB M, Beksac AT, Ferguson E, Kaviani A, et al
    Single-port Extraperitoneal and Transperitoneal Radical Prostatectomy: A Multi-Institutional Propensity-Score Matched Study.
    Urology. 2023;171:140-145.
    PubMed     Abstract available
    
    
    
47. ZHAO CC, Rossi JK, Wysock JS
    Systematic Review and Meta-Analysis of Free-Hand and Fixed-Arm Spatial Tracking Methodologies in Software-Guided MRI-TRUS Fusion Prostate Biopsy Platforms.
    Urology. 2023;171:16-22.
    PubMed     Abstract available
    
    
    
48. POZZI E, Ventimiglia E, Fallara G, Capogrosso P, et al
    Haemospermia in the Real- Life Setting: A New High-Risk Stratification.
    Urology. 2023;171:146-151.
    PubMed     Abstract available
    
    
    
49. LIU HQ, Ding W, Tao LS, Shen XD, et al
    Catheterization Before Transperineal Ultrasound-guided Prostate Biopsy and the Risk of Urethrorrhagia.
    Urology. 2023;171:23-28.
    PubMed     Abstract available
    
    
    
50. RAMOS F, Korets R, Fleishman A, Kaul S, et al
    Comparative Effectiveness of Magnetic Resonance Imaging-Ultrasound Fusion Versus In-bore Magnetic Resonance Imaging-targeted Prostate Biopsy.
    Urology. 2023;171:164-171.
    PubMed     Abstract available
    
    
    
51. PARIKH KD, Declouette B, Chen M, Rao S, et al
    Evaluating the Downstream Revenues of a Self-Pay Bi-Parametric Prostate MRI Program.
    Urology. 2023;171:109-114.
    PubMed     Abstract available
    
    
    December 2022
52. ANDOLFI C, Vickers AJ, Cooperberg MR, Carroll PR, et al
    Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue.
    Urology. 2022;170:154-160.
    PubMed     Abstract available
    
    
    November 2022
53. SIAPNO AED, Gaither TW, Tandel MD, Kwan L, et al
    Impact of Comprehensive Health Insurance on Quality of Life in Low-Income Hispanic Men with Prostate Cancer.
    Urology. 2022 Nov 15. pii: S0090-4295(22)00954.
    PubMed     Abstract available
    
    
    
54. MANN RA, Kasabwala K, Buckley JC, Smith TG, et al
    The "Fragile" Urethra as a Predictor of Early Artificial Urinary Sphincter Erosion.
    Urology. 2022;169:233-236.
    PubMed     Abstract available
    
    
    October 2022
55. KANABOLO D, True L, Vakar-Lopez F, Tretiakova M, et al
    Prostate-specific Antigen (PSA) Screening and a Lifesaving Cardiac Transplant.
    Urology. 2022;168:e1-e2.
    PubMed    
    
    
    
56. MORRISON JC, Sax-Bolder A, Gershman B, Konety B, et al
    Geographic Variation of Infectious Complications Following Prostate Biopsy in The United States: Results From a Population-Based Cohort of Privately Insured Patients.
    Urology. 2022;168:27-34.
    PubMed     Abstract available
    
    
    September 2022
57. CHOE S, Patel HD, Lanzotti N, Okabe Y, et al
    MRI vs Transrectal Ultrasound to Estimate Prostate Volume and PSAD: Impact on Prostate Cancer Detection.
    Urology. 2022 Sep 21. pii: S0090-4295(22)00806.
    PubMed     Abstract available
    
    
    
58. IMBER BS, O'Dwyer E, Lobaugh S, McBride SM, et al
    Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation.
    Urology. 2022 Sep 14. pii: S0090-4295(22)00779.
    PubMed     Abstract available
    
    
    
59. HUANG D, Yang X, Liu Y, Huang Z, et al
    Prostate Cancer presenting as a solitary sacral osteolytic metastasis mimicking chordoma on (18)F-FDG PET/CT.
    Urology. 2022 Sep 14. pii: S0090-4295(22)00798.
    PubMed    
    
    
    
60. INOUYE BM, Krischak MK, Krughoff K, Boysen WR, et al
    Resection of Pubic Symphysis and Cystectomy Significantly Improves Short-Term Patient-Reported Physical Functioning Among Patients With Pubovesical Fistula and Pubic Bone Osteomyelitis.
    Urology. 2022;167:218-223.
    PubMed     Abstract available
    
    
    
61. MOVASSAGHI M, Ahmed F, Patel H, Luk L, et al
    Association of Patient and Imaging-Related Factors With False Negative MRI-Targeted Prostate Biopsies of Suspicious PI-RADS 4 and 5 Lesions.
    Urology. 2022;167:165-170.
    PubMed     Abstract available
    
    
    August 2022
62. HARRINGTON SA, Fialk G, Raman JD
    RE: "Transperineal Prostate Biopsy is Associated With Lower Tissue Core Pathogen Burden Relative to Transrectal Biopsy: Mechanistic Underpinnings for Lower Infection Risk in the Transperineal Approach".
    Urology. 2022;166:297-298.
    PubMed    
    
    
    July 2022
63. OKABE Y, Patel HD, Rac G, Gupta GN, et al
    Multifocality of Prostate Cancer and Candidacy for Focal Therapy Based on Magnetic Resonance Imaging.
    Urology. 2022 Jul 29. pii: S0090-4295(22)00631.
    PubMed     Abstract available
    
    
    
64. NASSIRI N, Richardson S, Kuppermann D, Brisbane WG, et al
    Partial gland ablation of prostate cancer: Effects of Repeat Treatment.
    Urology. 2022 Jul 27. pii: S0090-4295(22)00617.
    PubMed     Abstract available
    
    
    
65. CALLEJAS MF, Klein EA, Truong M, Thomas L, et al
    Detection of clinically significant index prostate cancer using micro-ultrasound: correlation with radical prostatectomy.
    Urology. 2022 Jul 14. pii: S0090-4295(22)00592.
    PubMed     Abstract available
    
    
    
66. DE BARROS HA, Remmers S, Luiting HB, van Leenders GJLH, et al
    Predictive value of Cribriform and Intraductal Carcinoma for the Nomogram-Based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.
    Urology. 2022 Jul 5. pii: S0090-4295(22)00537.
    PubMed     Abstract available
    
    
    
67. WERNEBURG GT, Adler A, Zhang A, Mukherjee SD, et al
    Transperineal Prostate Biopsy is Associated With Lower Tissue Core Pathogen Burden Relative to Transrectal Biopsy: Mechanistic Underpinnings for Lower Infection Risk in the Transperineal Approach.
    Urology. 2022;165:1-8.
    PubMed     Abstract available
    
    
    
68. HARRISON R, Stifelman M, Billah M, Zaifman J, et al
    Propensity-Score Matched Analysis Between Extraperitoneal Single Port and Intraperitoneal Multiport Radical Prostatectomy: A Single-Institutional Experience.
    Urology. 2022;165:198-205.
    PubMed     Abstract available
    
    
    
69. LANE GI, Qi J, Dupati A, Ferrante S, et al
    Assessing the Impact of Decision Aid Use on Post Prostatectomy Patient Reported Outcomes.
    Urology. 2022;165:187-192.
    PubMed     Abstract available
    
    
    
70. SLOPNICK EA, Bagby C, Mahran A, Nagel C, et al
    Skene's Gland Malignancy: A Case Report and Systematic Review.
    Urology. 2022;165:36-43.
    PubMed     Abstract available
    
    
    June 2022
71. DELANEY RK, Sisco-Taylor BL, Wang X, Scherr K, et al
    Two Specialists, Two Recommendations: Discordance between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations.
    Urology. 2022 Jun 26. pii: S0090-4295(22)00512.
    PubMed     Abstract available
    
    
    
72. BENIDIR T, Hofmann M, Lone Z, Nguyen JK, et al
    Elevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature.
    Urology. 2022 Jun 6. pii: S0090-4295(22)00449.
    PubMed     Abstract available
    
    
    
73. JEONG SH, Werneburg GT, Abouassaly R, Wood H, et al
    Acquired and Congenital Spinal Cord Injury is Associated With Lower Likelihood of Prostate Specific Antigen Screening.
    Urology. 2022;164:178-183.
    PubMed     Abstract available
    
    
    
74. CHIU PKF, Ahmed HU, Rastinehad AR
    TRUS Biopsy vs Transperineal Biopsy for Suspicion of Prostate Cancer.
    Urology. 2022;164:18-20.
    PubMed    
    
    
    
75. TOSOIAN JJ, Singhal U, Davenport MS, Wei JT, et al
    Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.
    Urology. 2022;164:184-190.
    PubMed     Abstract available
    
    
    April 2022
76. GOLDENTHAL SB, Reimers MA, Singhal U, Farha M, et al
    Prostate Cancer with Peritoneal Carcinomatosis: A robotic-assisted radical prostatectomy-based Case Series.
    Urology. 2022 Apr 23. pii: S0090-4295(22)00296.
    PubMed     Abstract available
    
    
    March 2022
77. PINO MD, Abern MR, Moreira DM
    Prostate Cancer Disparities in Hispanics using the National Cancer Database.
    Urology. 2022 Mar 26. pii: S0090-4295(22)00256.
    PubMed     Abstract available
    
    
    
78. LOWENTRITT B, Brown G, Pilon D, Ellis L, et al
    Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer.
    Urology. 2022 Mar 19. pii: S0090-4295(22)00245.
    PubMed     Abstract available
    
    
    
79. NASRI J, Barthe F, Parekh S, Ratnani P, et al
    Nomogram predicting adverse pathology outcome on radical prostatectomy in low-risk prostate cancer men.
    Urology. 2022 Mar 6. pii: S0090-4295(22)00173.
    PubMed     Abstract available
    
    
    
80. KUPERUS JM, Tobert CM, Semerjian AM, Qi J, et al
    Pelvic Lymph Node Dissection at Radical Prostatectomy for Intermediate Risk Prostate Cancer: Assessing Utility and Nodal Metastases Within a Statewide Quality Improvement Consortium.
    Urology. 2022 Mar 6. pii: S0090-4295(22)00166.
    PubMed     Abstract available
    
    
    
81. BEARRICK EN, Findlay BL, Maciejko LA, Hebert KJ, et al
    Robotic Urethral Reconstruction Outcomes in Men With Posterior Urethral Stenosis.
    Urology. 2022;161:118-124.
    PubMed     Abstract available
    
    
    February 2022
82. MASON MM, Nackeeran S, Lokeshwar SD, Blachman-Braun R, et al
    PSA Testing in Men Receiving Testosterone Therapy with History of Prostate Cancer: A Matched Analysis of a Large Multi-Institutional Research Network.
    Urology. 2022 Feb 25. pii: S0090-4295(22)00161.
    PubMed     Abstract available
    
    
    
83. LIM M, Qureshi MM, Boyd G, Hirsch AE, et al
    Effect of Radiation Treatment at a High-Volume Center on Outcomes in Intermediate-Risk Prostate Cancer: An Analysis of the National Cancer Database.
    Urology. 2022 Feb 16. pii: S0090-4295(22)00144.
    PubMed     Abstract available
    
    
    
84. HACKER EC, Maganty A, Pere MM, Rusilko PJ, et al
    Outcomes of Vesicourethral Anastomotic Stenosis and Bladder Neck Contracture with Direct Visual Internal Urethrotomy with Mitomycin-C After Prostate Cancer Treatment.
    Urology. 2022 Feb 12. pii: S0090-4295(22)00110.
    PubMed     Abstract available
    
    
    
85. LAVI A, Yudkevich B, Pechansky S, Tzemach S, et al
    Author Reply.
    Urology. 2022;160:159.
    PubMed    
    
    
    January 2022
86. VERSALLE D, Qi J, Noyes S, Moriarity A, et al
    Practice-level variation in the decision to biopsy PI-RADS 3 lesions in favorable-risk prostate cancer patients.
    Urology. 2022 Jan 23. pii: S0090-4295(22)00070.
    PubMed     Abstract available
    
    
    
87. KOTAMARTI S, George A, Zhu A, Polascik TJ, et al
    Transrectal Ultrasound-Guided Biopsy Should Continue to Be a Standard of Care for The Detection of Prostate Cancer.
    Urology. 2022 Jan 14. pii: S0090-4295(22)00018.
    PubMed     Abstract available
    
    
    
88. ROEBUCK E, Sha W, Lu C, Miller C, et al
    Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate Cancer.
    Urology. 2022 Jan 4. pii: S0090-4295(21)01201.
    PubMed     Abstract available
    
    
    
89. REDMOND EJ, Doiron RC, Rourke KF
    Development of New Comorbidities in Patients Awaiting Urinary Incontinence Surgery Following Radical Prostatectomy.
    Urology. 2022;159:235-240.
    PubMed     Abstract available
    
    
    December 2021
90. NAKAI Y, Tanaka N, Asakawa I, Miyake M, et al
    Mirabegron reduces urinary frequency and improves overactive bladder symptoms at 3 months after (125)I-brachytherapy for prostate cancer: An open-labeled, randomized, non-placebo-controlled study.
    Urology. 2021 Dec 29. pii: S0090-4295(21)01183.
    PubMed     Abstract available
    
    
    
91. WITTMANN D, Varlamos C, Rodriguez-Galano N, Day L, et al
    Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction with a Survivorship Program Embedded in Urologic-oncologic Care.
    Urology. 2021 Dec 8. pii: S0090-4295(21)01153.
    PubMed     Abstract available
    
    
    
92. SABA P, Melnyk R, Holler T, Oppenheimer D, et al
    Comparison of Multi-Parametric MRI of the Prostate to 3D Prostate Computer Aided Designs and 3D-Printed Prostate Models for Pre-Operative Planning of Radical Prostatectomies: A Pilot Study.
    Urology. 2021;158:150-155.
    PubMed     Abstract available
    
    
    November 2021
93. LAVI A, Yudkevich B, Pechansky S, Tzemach S, et al
    Implications of a Novel Biopsy Downloading System on Prostate Cancer Detection Rate, Surveillance and Focal Therapy - A Prospective Study.
    Urology. 2021 Nov 12. pii: S0090-4295(21)01039.
    PubMed     Abstract available
    
    
    
94. VERTOSICK EA, Zappala S, Punnen S, Hugosson J, et al
    Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume.
    Urology. 2021;157:102-106.
    PubMed     Abstract available
    
    
    
95. LORENZ U, Samaseika Y, Balsmeyer U, Neumann N, et al
    Multicystic Prostate Tumor.
    Urology. 2021;157:41.
    PubMed    
    
    
    October 2021
96. SEIDEN B, Weng S, Sun N, Gordon D, et al
    NCCN Risk Reclassification in Black men with low and intermediate risk Prostate Cancer after genomic testing.
    Urology. 2021 Oct 21. pii: S0090-4295(21)00979.
    PubMed     Abstract available
    
    
    
97. SPITZNAGEL T, Hardenberg JV, Schmid FA, Rupp NJ, et al
    Salvage Robotic-assisted Laparoscopic Radical Prostatectomy Following Focal High-Intensity Focused Ultrasound for ISUP 2/3 Cancer.
    Urology. 2021;156:147-153.
    PubMed     Abstract available
    
    
    September 2021
98. ESDAILLE AR, Ibilibor C, Ii AH, Palmer NR, et al
    Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer.
    Urology. 2021 Sep 25. pii: S0090-4295(21)00893.
    PubMed     Abstract available
    
    
    
99. BERTOLO R, Garisto J, Bove P, Mottrie A, et al
    Perioperative Outcomes Between Single-Port and "Multi-Port" Robotic Assisted Radical Prostatectomy: Where do we stand?
    Urology. 2021;155:138-143.
    PubMed     Abstract available
    
    
    
100. DE LA CALLE CM, Shee K, Chu CE, Cowan JE, et al
     Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance.
     Urology. 2021;155:91-95.
     PubMed     Abstract available
     
     
     
101. PRESS BH, Khajir G, Ghabili K, Leung C, et al
     Utility of PSA Density in Predicting Upgraded Gleason Score in Men on Active Surveillance With Negative MRI.
     Urology. 2021;155:96-100.
     PubMed     Abstract available
     
     
     
102. SAYYID RK, Klotz L, Benton JZ, Lodh A, et al
     Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance Patients.
     Urology. 2021;155:117-123.
     PubMed     Abstract available
     
     
     
103. CHECCUCCI E, Piramide F, Amparore D, De Cillis S, et al
     Beyond the Learning Curve of Prostate MRI/TRUS Target Fusion Biopsy after More than 1000 Procedures.
     Urology. 2021;155:39-45.
     PubMed     Abstract available
     
     
     
104. CRICCO-LIZZA E, Wilcox Vanden Berg RN, Laviana A, Pantuck M, et al
     Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation.
     Urology. 2021;155:33-38.
     PubMed     Abstract available
     
     
     
105. LEE AY, Chen K, Law YM, Ho HS, et al
     Robot-assisted Magnetic Resonance Imaging-ultrasound Fusion Transperineal Targeted Biopsy.
     Urology. 2021;155:46.
     PubMed     Abstract available
     
     
     
106. WEI G, Papa N, Kelly B, Bolton D, et al
     Trends in the Uptake of Diagnostic Multi-Parametric MRI of the Prostate With Federal Funding: Australia Population Data.
     Urology. 2021;155:9-11.
     PubMed    
     
     
     
107. BRIGGS LG, Kim M, Gusev A, Rumpf F, et al
     Evaluation of In-Office MRI/US Fusion Transperineal Prostate Biopsy via Free-hand Device during Routine Clinical Practice.
     Urology. 2021;155:26-32.
     PubMed     Abstract available
     
     
     
108. LEVY A, Fleishman A, Jackson M, Waisman A, et al
     Using Preoperative Pelvic Floor Assessment to Predict Early Return of Continence after Robotic Radical Prostatectomy.
     Urology. 2021;155:160-164.
     PubMed     Abstract available
     
     
     
109. ALTOK M, Chapin BF, Matin SF, Achim MF, et al
     Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase.
     Urology. 2021;155:144-151.
     PubMed     Abstract available
     
     
     
110. MEHTA A, Kim WC, Aswad KG, Brunckhorst O, et al
     Erectile Function Post Prostate Biopsy: A Systematic Review and Meta-analysis.
     Urology. 2021;155:1-8.
     PubMed     Abstract available
     
     
     August 2021
111. BREE KK, Hensley PJ, Pettaway CA
     Germline Mutations in African American Men with Prostate Cancer: Incidence, Implications and Diagnostic Disparities.
     Urology. 2021 Aug 25. pii: S0090-4295(21)00796.
     PubMed     Abstract available
     
     
     
112. POSIELSKI N, Frankel J, Kuo HC, Ho O, et al
     IMPACT OF AGE AND RACE ON HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER.
     Urology. 2021 Aug 21. pii: S0090-4295(21)00783.
     PubMed     Abstract available
     
     
     
113. VINCE RA JR, Jamieson S, Mahal B, Iii WU, et al
     Examining the Racial Disparities in Prostate Cancer.
     Urology. 2021 Aug 18. pii: S0090-4295(21)00772.
     PubMed     Abstract available
     
     
     
114. BERG RNWV, Basourakos SP, Shoag J, Scherr D, et al
     Prostate Cancer Screening for Gay Men in the United States.
     Urology. 2021 Aug 8. pii: S0090-4295(21)00734.
     PubMed     Abstract available
     
     
     
115. JAMIESON SC, Mallory CW, Jivanji DR, Perez A, et al
     THE ROLE OF HEALTH LITERACY IN PROSTATE CANCER SCREENING.
     Urology. 2021 Aug 7. pii: S0090-4295(21)00735.
     PubMed     Abstract available
     
     
     
116. LEWICKI P, Arenas-Gallo C, Basourakos SP, Awamlh BAHA, et al
     Re: Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, et al. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. Urology 2021 Jun 26;S0090-4295(21)00539-2.
     Urology. 2021 Aug 3. pii: S0090-4295(21)00722.
     PubMed    
     
     
     
117. BORGES DA PONTE C, Leitao TP, Miranda M, Polido J, et al
     Prostate Ewing Sarcoma/PNET: A case of long survival in a highly aggressive malignancy.
     Urology. 2021;154:e11-e12.
     PubMed     Abstract available
     
     
     July 2021
118. DEROUEN MC, Yang J, Jain J, Weden MM, et al
     Disparities in prostate cancer survival according to neighborhood archetypes, a population-based study.
     Urology. 2021 Jul 22. pii: S0090-4295(21)00674.
     PubMed     Abstract available
     
     
     
119. PATEL HD, Doshi CP, Koehne EL, Hart S, et al
     African American Men have Increased Risk of Prostate Cancer Detection despite Similar Rates of Anterior Prostatic Lesions and PI-RADS Grade on Multiparametric Magnetic Resonance Imaging.
     Urology. 2021 Jul 21. pii: S0090-4295(21)00678.
     PubMed     Abstract available
     
     
     
120. SESSINE MS, Das S, Park B, Salami SS, et al
     Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
     Urology. 2021 Jul 16. pii: S0090-4295(21)00647.
     PubMed     Abstract available
     
     
     
121. GAYLIS F, Nasseri R, Salmasi A, Anderson C, et al
     Implementing Continuous Quality Improvement in an Integrated Community Urology Practice: Lessons Learned.
     Urology. 2021;153:139-146.
     PubMed     Abstract available
     
     
     
122. WARNER JN, Gallegos MA
     Letter to the Editor RE: Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
     Urology. 2021;153:359-360.
     PubMed    
     
     
     
123. SHAH N, Ioffe V
     Re: Letter to the Editor: Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis. Deepansh Dalela et al. (Urology 2021;148:1-3).
     Urology. 2021;153:360-361.
     PubMed    
     
     
     June 2021
124. PIERRE-VICTOR D, Parnes HL, Andriole GL, Pinsky PF, et al
     Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening.
     Urology. 2021 Jun 26. pii: S0090-4295(21)00539.
     PubMed     Abstract available
     
     
     
125. CHANDRASEKAR T, Bowler N, Schneider A, Goldberg H, et al
     Outcomes of Active Surveillance for Men with Intermediate Risk Prostate Cancer, A Population-Based Analysis.
     Urology. 2021 Jun 26. pii: S0090-4295(21)00560.
     PubMed     Abstract available
     
     
     
126. KAWA SM, Stroomberg HV, Larsen SB, Helgstrand JT, et al
     Detection of clinically significant prostate cancer by systematic TRUS-biopsies in a population-based setting over a 20 year period.
     Urology. 2021 Jun 22. pii: S0090-4295(21)00538.
     PubMed     Abstract available
     
     
     
127. CAMPBELL RA, Li J, Malone L, Levy DA, et al
     Correlative Analysis of Vitamin D and Omega-3 Fatty Acid Intake in Men on Active Surveillance for Prostate Cancer.
     Urology. 2021 Jun 15. pii: S0090-4295(21)00525.
     PubMed     Abstract available
     
     
     
128. SOERENSEN SJC, Thomas IC, Schmidt B, Daskivich T, et al
     Reply to the Editorial Comment on: Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021.
     Urology. 2021 Jun 14. pii: S0090-4295(21)00488.
     PubMed     Abstract available
     
     
     
129. CHAO B, Lepor H
     5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer.
     Urology. 2021 Jun 3. pii: S0090-4295(21)00460.
     PubMed     Abstract available
     
     
     May 2021
130. HESTERBERG AB, Gordetsky JB, Hurley PJ
     Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.
     Urology. 2021 May 28. pii: S0090-4295(21)00442.
     PubMed     Abstract available
     
     
     
131. KING MC, Sardi A, Velez-Mejia C, Sittig M, et al
     Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate Cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
     Urology. 2021 May 25. pii: S0090-4295(21)00435.
     PubMed     Abstract available
     
     
     
132. ARMSTRONG N, Bahl A, Pinkawa M, Ryder S, et al
     SpaceOAR Hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review.
     Urology. 2021 May 22. pii: S0090-4295(21)00421.
     PubMed     Abstract available
     
     
     
133. SCHUBBE ME, Gellhaus PT, Tobert CM, Mott SL, et al
     Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life.
     Urology. 2021 May 7. pii: S0090-4295(21)00368.
     PubMed     Abstract available
     
     
     
134. KF R
     Re: Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
     Urology. 2021 May 1. pii: S0090-4295(21)00355.
     PubMed    
     
     
     April 2021
135. PAUDEL R, Ferrante S, Qi J, Dunn RL, et al
     Patient preferences and treatment decisions for prostate cancer: Results from a statewide urological quality improvement collaborative.
     Urology. 2021 Apr 29. pii: S0090-4295(21)00350.
     PubMed     Abstract available
     
     
     
136. NORRIS JM, Ball R, Freeman A, Ghei M, et al
     Patient Perspectives and Understanding of MRI-Directed Prostate Cancer Diagnosis.
     Urology. 2021 Apr 3. pii: S0090-4295(21)00301.
     PubMed    
     
     
     March 2021
137. MADI R, Sayyid RK, Hiffa A, Thomas E, et al
     Early Experience with Salvage Retzius-sparing Robotic-assisted Radical Prostatectomy: Oncologic and Functional Outcomes.
     Urology. 2021;149:117-121.
     PubMed     Abstract available
     
     
     
138. LINDSAY J, Uribe S, Moschonas D, Pavlakis P, et al
     Patient Satisfaction and Regret After Robot-assisted Radical Prostatectomy: A Decision Regret Analysis.
     Urology. 2021;149:122-128.
     PubMed     Abstract available
     
     
     
139. NAITO H, Kato T, Ishikawa R, Tanaka K, et al
     The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 2.
     Urology. 2021;149:174-180.
     PubMed     Abstract available
     
     
     
140. WONG D, Rincon J, Henning G, Smith Z, et al
     Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates.
     Urology. 2021;149:129-132.
     PubMed     Abstract available
     
     
     
141. GUERRIOS-RIVERA L, Howard LE, Klaassen Z, Terris MK, et al
     Do Hispanic Men Have Worse Outcomes After Radical Prostatectomy? Results From SEARCH.
     Urology. 2021;149:181-186.
     PubMed     Abstract available
     
     
     February 2021
142. SAPIENZA LG, Ning MS, Carvalho EF, Spratt D, et al
     Efficacy and Incontinence Rates After Urethroplasty for Radiation-Induced Urethral Stenosis: A Systematic Review and Meta-Analysis.
     Urology. 2021 Feb 22. pii: S0090-4295(21)00190.
     PubMed     Abstract available
     
     
     
143. DALELA D, Sood A, Keeley J, Rogers C, et al
     Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis.
     Urology. 2021;148:1-3.
     PubMed    
     
     
     
144. KUBOTA M, Matsuoka T, Yamasaki T, Kokubun H, et al
     Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy.
     Urology. 2021;148:151-158.
     PubMed     Abstract available
     
     
     
145. ETAFY MH, Katz JE, Gonzalgo MR, Garcia Lopez EA, et al
     Holmium Laser Enucleation of Prostate Within 6 Weeks of Transrectal Ultrasound Guided Prostate Biopsy is Safe and Effective.
     Urology. 2021;148:88-92.
     PubMed     Abstract available
     
     
     January 2021
146. HUANG MM, Patel HD, Wainger JJ, Su ZT, et al
     Comparison of Perioperative and Pathologic Outcomes Between Single-port and Standard Robot-assisted Radical Prostatectomy: An Analysis of a High-volume Center and the Pooled World Experience.
     Urology. 2021;147:223-229.
     PubMed     Abstract available
     
     
     January 2020
147. PATEL MS, Halpern JA, Desai AS, Keeter MK, et al
     Success of Prostate and Testicular Cancer Awareness Campaigns Compared to Breast Cancer Awareness Month According to Internet Search Volumes: A Google Trends Analysis.
     Urology. 2020 Jan 27. pii: S0090-4295(20)30081.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.